You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

27 Results
Drug
Other Name(s): Alkeran®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Neulasta® , Lapelga™ , Fulphila™ , Ziextenzo® , Nyvepria™
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2022
Drug
Other Name(s): Matulane®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 2019
Drug
Other Name(s): Provera® (multiple brands available)
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2015
Drug
Other Name(s): Megace® (multiple brands available)
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2016
Drug
Other Name(s): Purinethol®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Quick Link(s): Drug Monograph, Patient Info Sheet
Nov 2022
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
  • megestrol - oral tablets
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
megestrol
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2016
Regimen
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
  • prednisone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
mitoXANTRONE,
prednisone
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2016
Regimen
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lomustine,
procarbazine,
vinCRIStine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2023
Regimen
Cancer Type:
Endocrine, 
Adrenal
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    mitotane
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
mitotane
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2021
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    melphalan - oral tablets
ODB - General Benefit
    prednisone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
melphalan,
prednisone
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019

Pages